Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture

被引:0
|
作者
A. Verroken
L. Defourny
L. Lechgar
A. Magnette
M. Delmée
Y. Glupczynski
机构
[1] Université catholique de Louvain,Institut de recherche expérimentale et clinique (IREC), pôle de microbiologie (MBLG)
[2] Cliniques universitaires Saint-Luc—Université catholique de Louvain,Laboratoire de microbiologie
[3] CHU Dinant Godinne | UCL Namur,National Reference Centre for Monitoring of Antimicrobial Resistance in Gram
关键词
Blood Culture; Bloodstream Infection; Positive Blood Culture; Blood Culture Bottle; Bacteremic Episode;
D O I
暂无
中图分类号
学科分类号
摘要
Speeding up the turn-around time of positive blood culture identifications is essential in order to optimize the treatment of septic patients. Several sample preparation techniques have been developed allowing direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) identification of positive blood cultures. Yet, the hands-on time restrains their routine workflow. In this study, we evaluated an approach whereby MALDI-TOF MS identification without any additional steps was carried out on short subcultured colonies from positive blood bottles with the objective of allowing results reporting on the day of positivity detection. Over a 7-month period in 2012, positive blood cultures detected by 9 am with an automated system were inoculated onto a Columbia blood agar and processed after a 5-h incubation on a MALDI-TOF MicroFlex platform (Bruker Daltonik GmbH). Single-spotted colonies were covered with 1 μl formic acid and 1 μl matrix solution. The results were compared to the validated identification techniques. A total of 925 positive blood culture bottles (representing 470 bacteremic episodes) were included. Concordant identification was obtained in 727 (81.1 %) of the 896 monomicrobial blood cultures, with failure being mostly observed with anaerobes and yeasts. In 17 episodes of polymicrobic bacteremia, the identification of one of the two isolates was achieved in 24/29 (82.7 %) positive cultures. Routine implementation of MALDI-TOF MS identification on young positive blood subcultures provides correct results to the clinician in more than 80 % of the bacteremic episodes and allows access to identification results on the day of blood culture positivity detection, potentially accelerating the implementation of targeted clinical treatments.
引用
收藏
页码:405 / 413
页数:8
相关论文
共 50 条
  • [31] The impact of delayed analysis of positive blood cultures on the performance of short-term culture followed by MALDI-TOF MS
    Johnsson, Alexander T. A.
    Wong, Alicia Y. W.
    Ozenci, Volkan
    JOURNAL OF MICROBIOLOGICAL METHODS, 2020, 177
  • [32] Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS
    Yu, Jiajia
    Liu, Jingxian
    Li, Yuanrui
    Yu, Jing
    Zhu, Weinan
    Liu, Ying
    Shen, Lisong
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2018, 17
  • [33] An Automated Sample Preparation Instrument to Accelerate Positive Blood Cultures Microbial Identification by MALDI-TOF Mass Spectrometry (Vitek®MS)
    Broyer, Patrick
    Perrot, Nadine
    Rostaing, Herve
    Blaze, Jerome
    Pinston, Frederic
    Gervasi, Gaspard
    Charles, Marie-Helene
    Dachaud, Fabien
    Dachaud, Jacques
    Moulin, Frederic
    Cordier, Sylvain
    Dauwalder, Olivier
    Meugnier, Helene
    Vandenesch, Francois
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [34] MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures
    Bille, E.
    Dauphin, B.
    Leto, J.
    Bougnoux, M. -E.
    Beretti, J. -L.
    Lotz, A.
    Suarez, S.
    Meyer, J.
    Join-Lambert, O.
    Descamps, P.
    Grall, N.
    Mory, F.
    Dubreuil, L.
    Berche, P.
    Nassif, X.
    Ferroni, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (11) : 1117 - 1125
  • [35] Accelerated microbial identification "directly" from positive blood cultures using MALDI-TOF MS: Local clinical laboratory challenges
    Vaishnav, Madhumati S.
    Deepalakshmi, P. D.
    Hegadi, Sneha S.
    Divya, C.
    Murthy, Kotamballi N. Chidambara
    Srikanta, Sathyanarayana
    Prasad, Sujay R.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2024, 109 (03)
  • [36] Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS
    Jiajia Yu
    Jingxian Liu
    Yuanrui Li
    Jing Yu
    Weinan Zhu
    Ying Liu
    Lisong Shen
    Annals of Clinical Microbiology and Antimicrobials, 17
  • [37] Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures
    Wilhelm, Camila Morschbacher
    Moreira, Natalia Kehl
    Inamine, Everton
    Caierao, Juliana
    Barth, Afonso Luis
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (01) : 171 - 175
  • [38] Evaluation of the ceftazidime/avibactam and meropenem susceptibility by MALDI-TOF MS directly from positive blood cultures
    Camila Mörschbächer Wilhelm
    Natália Kehl Moreira
    Everton Inamine
    Juliana Caierão
    Afonso Luís Barth
    European Journal of Clinical Microbiology & Infectious Diseases, 2024, 43 : 171 - 175
  • [39] Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures
    Verroken, Alexia
    Defourny, Lydwine
    de Waroux, Olivier le Polain
    Belkhir, Leila
    Laterre, Pierre-Francois
    Delmee, Michel
    Glupczynski, Youri
    PLOS ONE, 2016, 11 (05):
  • [40] Performance of microbial identification by MALDI-TOF MS and susceptibility testing by VITEK 2 from positive blood cultures after minimal incubation on solid media
    S. L. Mitchell
    K. Alby
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 2201 - 2206